Spero Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on Tuesday, August 12, 2025

Core Insights - Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for rare diseases and multi-drug resistant bacterial infections [1][3] - The company will host a conference call on August 12, 2025, at 4:30 p.m. ET to report its financial results for the second quarter of 2025 and provide a business update [1] Company Information - Spero Therapeutics is headquartered in Cambridge, Massachusetts [3] - The company specializes in addressing high unmet needs in the treatment of rare diseases and multi-drug resistant bacterial infections [3] - For further information, Spero Therapeutics maintains an investor relations page on their corporate website [2][3]